Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis

Burska, A, El-Jawhari, J, Wu, J orcid.org/0000-0001-6093-599X et al. (6 more authors) (2020) Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis. Clinical and Experimental Rheumatology. ISSN 0392-856X

Abstract

Metadata

Authors/Creators:
Dates:
  • Accepted: 20 April 2020
  • Published (online): 21 July 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Dentistry (Leeds) > Applied Health and Clinical Translation (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Funding Information:
FunderGrant number
Versus Arthritis (formerly ARUK)20666
Versus Arthritis (formerly ARUK)19335
Depositing User: Symplectic Publications
Date Deposited: 27 May 2020 11:43
Last Modified: 01 Oct 2020 13:28
Published Version: https://www.clinexprheumatol.org/abstract.asp?a=14...
Status: Published online
Publisher: Pacini Editore SpA

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export